Non-selective Dopamine Agonists
| Cat. No. | Product Name / Activity |
|---|---|
| 2073 | (R)-(-)-Apomorphine hydrochloride |
| Dopamine agonist; non-subtype-selective | |
| 0427 | Bromocriptine mesylate |
| D2-like agonist (D2>D3>D4) | |
| 2664 | Cabergoline |
| D2-like agonist (D2>D3>D4) | |
| 6354 | CNV Dopamine |
| Caged dopamine; photolysed by UV light | |
| 0475 | Dihydroergotamine mesylate |
| D2-like partial agonist; also α-adrenergic partial agonist and 5-HT antagonist | |
| 3548 | Dopamine hydrochloride |
| Endogenous agonist at dopamine D1-5 receptors | |
| 4052 | Lisuride maleate |
| Dopamine agonist; antiparkinson's agent | |
| 1644 | Mesulergine hydrochloride |
| D2-like partial agonist; also 5-HT2A and 5-HT2C antagonist | |
| 1519 | Quinelorane hydrochloride |
| D2 and D3 agonist | |
| 1061 | (-)-Quinpirole hydrochloride |
| Selective D2-like agonist | |
| 3680 | Ropinirole |
| Selective D2-like agonist |
Dopamine Scientific Review
Our Dopamine receptors review gives an overview of the dopamine receptor subtypes, and the receptor agonists and antagonists used to study them.
Request copyRequest PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDFSchizophrenia Life Science Poster
Written by Justin M. Saunders and Javier González-Maeso
Our Schizophrenia poster highlights the targets and pathways representing the most promising strategies to pursue for novel drug development.
Request copyDownload PDF